<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Wacker Biotech</title>
    <link>https://www.biospace.com/employer/1824299/wacker-biotech</link>
    <description>Wacker Biotech</description>
    <language>en-US</language>
    <lastBuildDate>Wed, 28 Jun 2023 08:06:06 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/1824299/wacker-biotech.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Caeregen Therapeutics and Wacker Biotech Announce Collaboration Agreement to Produce the Regenerative Medicine Clinical Candidate CTR-107 (Noregen™) for Retinal Diseases</title>
      <link>https://www.biospace.com/caeregen-therapeutics-and-wacker-biotech-announce-collaboration-agreement-to-produce-the-regenerative-medicine-clinical-candidate-ctr-107-noregen-for-retinal-diseases</link>
      <description>Caeregen Therapeutics, a regenerative medicine therapeutics company and Wacker Biotech, a contract development and manufacturing organization, will collaborate on the development and production of CTR-107, a novel regenerative therapeutic for the treatment of retinal-related vision loss.</description>
      <pubDate>Wed, 28 Jun 2023 08:06:06 GMT</pubDate>
      <guid>https://www.biospace.com/caeregen-therapeutics-and-wacker-biotech-announce-collaboration-agreement-to-produce-the-regenerative-medicine-clinical-candidate-ctr-107-noregen-for-retinal-diseases</guid>
    </item>
    <item>
      <title>Pantherna and WACKER Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals</title>
      <link>https://www.biospace.com/press-releases/pantherna-and-wacker-intensify-collaboration-in-the-development-and-production-of-mrna-biopharmaceuticals</link>
      <description />
      <pubDate>Fri, 05 Apr 2024 15:41:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/pantherna-and-wacker-intensify-collaboration-in-the-development-and-production-of-mrna-biopharmaceuticals</guid>
    </item>
    <item>
      <title>WACKER Expands Production Capacity for Biopharmaceuticals in San Diego</title>
      <link>https://www.biospace.com/press-releases/wacker-expands-production-capacity-for-biopharmaceuticals-in-san-diego</link>
      <description />
      <pubDate>Mon, 06 May 2024 15:48:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/wacker-expands-production-capacity-for-biopharmaceuticals-in-san-diego</guid>
    </item>
    <item>
      <title>WACKER Opens mRNA Competence Center in Halle an der Saale, Germany</title>
      <link>https://www.biospace.com/press-releases/wacker-opens-mrna-competence-center-in-halle-an-der-saale-germany</link>
      <description />
      <pubDate>Mon, 03 Jun 2024 15:51:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/wacker-opens-mrna-competence-center-in-halle-an-der-saale-germany</guid>
    </item>
    <item>
      <title>WACKER &amp; CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion &amp; Qualification</title>
      <link>https://www.biospace.com/press-releases/wacker-cordenpharma-enter-pandemic-readiness-on-1-june-2024-after-successful-expansion-qualification</link>
      <description />
      <pubDate>Wed, 19 Jun 2024 16:01:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/wacker-cordenpharma-enter-pandemic-readiness-on-1-june-2024-after-successful-expansion-qualification</guid>
    </item>
    <item>
      <title>MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus</title>
      <link>https://www.biospace.com/press-releases/minervax-and-wacker-biotech-announce-manufacturing-collaboration-for-prophylactic-vaccine-targeting-group-b-streptococcus</link>
      <description />
      <pubDate>Tue, 17 Sep 2024 16:05:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/minervax-and-wacker-biotech-announce-manufacturing-collaboration-for-prophylactic-vaccine-targeting-group-b-streptococcus</guid>
    </item>
    <item>
      <title>Wacker Biotech announces strategic collaboration with RNAV8 Bio to enhance mRNA therapeutics development</title>
      <link>https://www.biospace.com/press-releases/wacker-biotech-announces-strategic-collaboration-with-rnav8-bio-to-enhance-mrna-therapeutics-development</link>
      <description>· The companies will offer complementary services for developing and producing mRNA-based therapies. · WACKER provides pDNA/mRNA manufacturing and lipid formulation; RNAV8 offers an mRNA engineering platform. · Engineering non-coding regions of mRNA sequences enhances drug efficacy. · This collaboration positions WACKER and RNAV8 as premium mRNA service providers.</description>
      <pubDate>Wed, 02 Apr 2025 13:54:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/wacker-biotech-announces-strategic-collaboration-with-rnav8-bio-to-enhance-mrna-therapeutics-development</guid>
    </item>
    <item>
      <title>Ready and running – WACKER Biotechnology Center in Munich</title>
      <link>https://www.biospace.com/press-releases/ready-and-running-wacker-biotechnology-center-in-munich</link>
      <description>· Additional research capacities set to accelerate growth in the Biosolutions division · A 1,500-square-meter laboratory and technical competence center and 700 square meters of office space present ideal conditions at the company’s central research location in Munich · The focus will be on research in manufacturing processes for biopharmaceuticals and ingredients for food and dietary supplements</description>
      <pubDate>Wed, 09 Jul 2025 14:09:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/ready-and-running-wacker-biotechnology-center-in-munich</guid>
    </item>
    <item>
      <title>WACKER and Gearbox Biosciences announce strategic collaboration to advance plasmid DNA manufacturing technologies</title>
      <link>https://www.biospace.com/press-releases/wacker-and-gearbox-biosciences-announce-strategic-collaboration-to-advance-plasmid-dna-manufacturing-technologies</link>
      <description>Joint press release by WACKER and Gearbox Biosciences · The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines · Focus on innovative workflows for antibiotic-free pDNA manufacturing and difficult-to-manufacture sequences · Joint solutions promise better scalability, efficiency and cost-effectiveness in production</description>
      <pubDate>Wed, 06 Aug 2025 14:17:00 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/wacker-and-gearbox-biosciences-announce-strategic-collaboration-to-advance-plasmid-dna-manufacturing-technologies</guid>
    </item>
  </channel>
</rss>
